When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACOR - Acorda Therapeutics: Managing The Transition
Acorda Therapeutics Inc.
Today, we take our first look at Acorda Therapeutics which has two approved products on the market.
One of these is seeing increasing generic competition while the other is ramping up sales. The company recently announced a significant workforce reduction to reduce costs.
Can Acorda manage this transition without diluting shareholders? A full investment analysis follows in the paragraphs below.